about
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?Potential for developing purinergic drugs for gastrointestinal diseasesPharmGKB: the Pharmacogenomics Knowledge Base.Antiplatelet drug interactions with proton pump inhibitorsPharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions.PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19.CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) studyThe risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han populationPharmacogenetics and cardiovascular disease--implications for personalized medicineDeciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment.Potent and Orally Bioavailable Antiplatelet Agent, PLD-301, with the Potential of Overcoming Clopidogrel ResistanceEffects of omeprazole or pantoprazole on platelet function in non-ST-segment elevation acute coronary syndrome patients receiving clopidogrel.Pharmacogenomics of anti-platelet and anti-coagulation therapy.Clopidogrel IBS Patients Have Higher Incidence of Gastrointestinal Symptoms Influenced by Age and Gender.Personalizing antiplatelet prescribing using genetics for patients undergoing percutaneous coronary intervention.Prasugrel suppresses development of lithium-induced nephrogenic diabetes insipidus in mice.Prophylactic Antiplatelet Medication in Endovascular Treatment of Intracranial Aneurysms: Low-Dose Prasugrel versus Clopidogrel.The PARTHENON Clinical Development Program: the Role of Ticagrelor in Patients with Atherothrombotic Disease.Platelet aggregation pathway.Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite.Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells.The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants.Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study.Leveraging the Learning Health Care Model to Improve Equity in the Age of Genomic Medicine.Uridine Adenosine Tetraphosphate-Induced Coronary Relaxation Is Blunted in Swine With Pressure Overload: A Role for Vasoconstrictor Prostanoids.
P2860
Q26801867-E3F52017-750F-454A-8BA5-FA9AD96FE65FQ26823542-1D326B13-4BF8-46E0-83D1-5C9910244905Q27000719-CD53CEDF-0722-4D90-B1E6-B277D8BA50F2Q33855594-B1B8548D-1700-41B2-A08E-55099CEE954FQ33948811-628163D2-9A8C-4397-B176-88EC75311518Q34161006-46DC0D64-789E-4AF1-AC39-0F2E494AAD21Q35952367-5D188D91-C267-44F3-ACCE-884298CE212DQ36141942-D0B17EA7-6B4F-44D3-9E61-E12E915ED740Q36328226-50BC47B3-F7E0-4A3B-9D93-81A81C3793F7Q36974672-EF58E68D-569B-437D-8ECA-C2479C402D59Q37132873-289CEB89-FAF2-4EC2-A1DC-7E869875E940Q37204050-35B6D454-D941-4CB2-82C1-8A6163865EC3Q37508880-51DAC7A0-D978-4A0E-9854-022A2D48BE0CQ38116753-E2D025E7-17C0-4B5A-AA5E-999D495ED1DCQ38608763-0AF74CF3-4316-4F3D-9D6E-7D6F697193D6Q38682772-942D8F10-344E-4011-A0A0-E1A7754346ECQ38944892-0EAF42F8-2119-44E6-B045-16ACF7F93C88Q39622468-F8A408A4-7128-446B-9372-7CEA68B3AB9AQ41456276-541FD4A9-7D9E-49D5-A7FC-35ED8BFB2E44Q42796609-1E878166-8C8B-4046-AF58-456E32ACEACDQ47094164-F8F4BFED-9751-40DD-A286-E1104146B70EQ47335450-2193081F-5614-4982-93D3-074134DA2B81Q50199930-C933F479-AB5E-43F8-8500-F2113E17942CQ52682104-7976DA10-57F6-4007-BE1B-3DC19D10EA32Q53452251-684EA672-60DA-4B88-9240-C9F72E6BB7C0Q55084123-7B90FACC-0817-434A-8B10-0A62FBC405AC
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Clopidogrel pathway.
@en
type
label
Clopidogrel pathway.
@en
prefLabel
Clopidogrel pathway.
@en
P2860
P1476
Clopidogrel pathway.
@en
P2093
Katrin Sangkuhl
Teri E Klein
P2860
P304
P356
10.1097/FPC.0B013E3283385420
P50
P577
2010-07-01T00:00:00Z